Anti-Infective Drugs Market - Forecast(2019 - 2024)

Report Code: HCR 0149 Report Format: PDF + Excel (Delivery in 48 Hrs)
Anti-infective drugs can be defined as drugs which are capable of killing an infectious agent or inhibit it from spreading and are used for the purpose of killing and/or suppressing the infection causing organisms from invading the host organism by means of its replication or releasing variety of toxins in the host. Such infection causing micro-organisms include viruses, bacteria, fungi, viroids and macro parasites. This report is focused on identifying market size for anti-infective drugs globally. Increasing patient pool globally is one of the major drivers for the growth of the anti-infective drugs coupled with increasing R&D activities and increasing approval for new drugs.

This report identifies the anti-infective drugs market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to anti-infective drugs market.

Anti-Infective Drugs Market

Globally North America dominated market for anti-infective drugs in 2015 due to higher awareness about migraine and its effects and is estimated to continue the same during the period of study. North America was followed by Europe and Asia-Pacific as the second and third largest markets respective in 2015. Demand for anti-infective drugs in the Asia-Pacific region is estimated to be grow fastest during the period of study and is expected to be driven by large population pool, government initiatives of undertaking various control programs and private partnership projects and rising cost containment initiatives by drug manufacturers. This report on global anti-infective drugs also covers different classes of anti-infective drugs available and market size in various geographical regions.
  • On the basis of anti-infective drug type this report classifies as follows covering all major types of drugs available in the market: Antifungals (Allylamines, Azoles, Polyene Macrolides and Other Antifungals Diuretics), Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines and Others Calcium channel blockers), Antivirals (Nucleoside Analogs, Transcriptase Inhibitors, DNA Polymerase Inhibitors, Protease Inhibitors and Other Antivirals Angiotensin-converting enzyme (ACE) inhibitors)
  • This report on global anti-infective drugs is also classified on the basis of infection type covering all major types of infections as follows: HIV, Hepatitis B, Hepatitis C, Urinary Tract, Respiratory Candidiasis and Other Infections
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for anti-infective drugs in each of the region.

Sample Companies Profiled in this Report are: 

  • Abbott Laboratories
  • Alcon Pharmaceuticals Ltd.  
  • Astellas Pharma Inc.   
  • AstraZeneca Plc     
  • Bayer HealthCare AG
  • 10+
1. Anti-Infective Drugs Market - Overview
1.1. Definitions and Scope
2. Anti-Infective Drugs Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Anti-Infective Drugs Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Anti-Infective Drugs Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Anti-Infective Drugs Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Anti-Infective Drugs Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Anti-Infective Drugs Market - Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Anti-Infective Drugs Market – By Drugs Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Antifungals
8.3.1.1. Allylamines
8.3.1.2. Azoles
8.3.1.3. Polyene Macrolides
8.3.1.4. Other Antifungals Diuretics
8.3.2. Antibacterials
8.3.2.1. Aminoglycosides
8.3.2.2. Carbapenems
8.3.2.3. Cephalosporins
8.3.2.4. Macrolides
8.3.2.5. Penicillins
8.3.2.6. Quinolones
8.3.2.7. Sulfonamides
8.3.2.8. Tetracyclines
8.3.2.9. Others Calcium channel blockers
8.3.3. Antivirals
8.3.3.1. Nucleoside Analogs
8.3.3.2. Transcriptase Inhibitors
8.3.3.3. DNA Polymerase Inhibitors
8.3.3.4. Protease Inhibitors
8.3.3.5. Other Antivirals Angiotensin-converting enzyme (ACE) inhibitors
9. Anti-Infective Drugs Market – By Infection (Market Size -$Million / $Billion)
9.1. HIV
9.2. Hepatitis B
9.3. Hepatitis C
9.4. Urinary Tract
9.5. Respiratory Candidiasis
9.6. Respiratory Candidiasis
10. Anti-Infective Drugs - By Geography (Market Size -$Million / $Billion)
10.1. Anti-Infective Drugs Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Anti-Infective Drugs - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Anti-Infective Drugs - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Anti-Infective Drugs – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Anti-Infective Drugs Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Anti-Infective Drugs Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Anti-Infective Drugs Market – Key Company List by Country Premium
14. Anti-Infective Drugs Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Abbott Laboratories
14.3. Alcon Pharmaceuticals Ltd.
14.4. Astellas Pharma Inc.
14.5. AstraZeneca Plc
14.6. Bayer HealthCare AG
14.7. Bristol-Myers Squibb Co.
14.8. Boehringer Ingelheim
14.9. Sanofi-Aventis SA 
14.10. Novartis AG
14.11. GlaxoSmithKline Plc
14.12. Company 11
14.13. Company 12
14.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Anti-Infective Drugs Market - Appendix
15.1. Abbreviations
15.2. Sources
16. Anti-Infective Drugs Market - Methodology
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables

Table 1: Anti-Infective Drugs Market Overview 2019-2024
Table 2: Anti-Infective Drugs Market Leader Analysis 2018-2019 (US$)
Table 3: Anti-Infective Drugs Market Product Analysis 2018-2019 (US$)
Table 4: Anti-Infective Drugs Market End User Analysis 2018-2019 (US$)
Table 5: Anti-Infective Drugs Market Patent Analysis 2013-2018* (US$)
Table 6: Anti-Infective Drugs Market Financial Analysis 2018-2019 (US$)
Table 7: Anti-Infective Drugs Market Driver Analysis 2018-2019 (US$)
Table 8: Anti-Infective Drugs Market Challenges Analysis 2018-2019 (US$)
Table 9: Anti-Infective Drugs Market Constraint Analysis 2018-2019 (US$)
Table 10: Anti-Infective Drugs Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Anti-Infective Drugs Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Anti-Infective Drugs Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Anti-Infective Drugs Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Anti-Infective Drugs Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Anti-Infective Drugs Market Value Chain Analysis 2018-2019 (US$)
Table 16: Anti-Infective Drugs Market Pricing Analysis 2019-2024 (US$)
Table 17: Anti-Infective Drugs Market Opportunities Analysis 2019-2024 (US$)
Table 18: Anti-Infective Drugs Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Anti-Infective Drugs Market Supplier Analysis 2018-2019 (US$)
Table 20: Anti-Infective Drugs Market Distributor Analysis 2018-2019 (US$)
Table 21: Anti-Infective Drugs Market Trend Analysis 2018-2019 (US$)
Table 22: Anti-Infective Drugs Market Size 2018 (US$)
Table 23: Anti-Infective Drugs Market Forecast Analysis 2019-2024 (US$)
Table 24: Anti-Infective Drugs Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 26: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Antifungals, 2019-2024 ($)
Table 27: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Allylamines, 2019-2024 ($)
Table 28: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Antibacterials, 2019-2024 ($)
Table 29: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Aminoglycosides, 2019-2024 ($)
Table 30: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Antivirals, 2019-2024 ($)
Table 31: Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 32: Anti-Infective Drugs Market By Infection, Revenue & Volume,By HIV, 2019-2024 ($)
Table 33: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Hepatitis B, 2019-2024 ($)
Table 34: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Hepatitis C, 2019-2024 ($)
Table 35: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Urinary Tract, 2019-2024 ($)
Table 36: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Respiratory Candidiasis, 2019-2024 ($)
Table 37: North America Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 38: North America Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 39: South america Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 40: South america Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 41: Europe Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 42: Europe Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 43: APAC Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 44: APAC Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 45: Middle East & Africa Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 46: Middle East & Africa Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 47: Russia Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 48: Russia Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 49: Israel Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 50: Israel Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 51: Top Companies 2018 (US$)Anti-Infective Drugs Market, Revenue & Volume
Table 52: Product Launch 2018-2019Anti-Infective Drugs Market, Revenue & Volume
Table 53: Mergers & Acquistions 2018-2019Anti-Infective Drugs Market, Revenue & Volume


List of Figures

Figure 1: Overview of Anti-Infective Drugs Market 2019-2024
Figure 2: Market Share Analysis for Anti-Infective Drugs Market 2018 (US$)
Figure 3: Product Comparison in Anti-Infective Drugs Market 2018-2019 (US$)
Figure 4: End User Profile for Anti-Infective Drugs Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Anti-Infective Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Anti-Infective Drugs Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Anti-Infective Drugs Market 2018-2019
Figure 8: Ecosystem Analysis in Anti-Infective Drugs Market 2018
Figure 9: Average Selling Price in Anti-Infective Drugs Market 2019-2024
Figure 10: Top Opportunites in Anti-Infective Drugs Market 2018-2019
Figure 11: Market Life Cycle Analysis in Anti-Infective Drugs Market
Figure 12: GlobalBy Drugs TypeAnti-Infective Drugs Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy InfectionAnti-Infective Drugs Market Revenue, 2019-2024 ($)
Figure 14: Global Anti-Infective Drugs Market - By Geography
Figure 15: Global Anti-Infective Drugs Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Anti-Infective Drugs Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 18: US Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 93: China Anti-Infective Drugs Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Anti-Infective Drugs Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Anti-Infective Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Anti-Infective Drugs Market 
Figure 131: Developments, 2018-2019*Anti-Infective Drugs Market 
Figure 132: Company 1 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)